Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Drugeon

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Chemotherapy|January 1, 1982
The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutantsH B Drugeon, A L Courtieu
Pathologie-Biologie|June 1, 1987
[Susceptibility of Campylobacter pyloridis to antibiotics]C Freland, B Massoubre, H B Drugeon
Fundamental & Clinical Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetilR Garraffo, H B Drugeon, D Chiche
Lancet (London, England)|March 10, 1990
Non-tuberculous mycobacterial tenosynovitisF Raffi, D Moinard, H B Drugeon
Pathologie-Biologie|May 1, 1987
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination]H B Drugeon, P Dellamonica, J Caillon
La Revue Du Praticien|April 11, 1987
[The Staphylococcus in 1987]D Baron, H B Drugeon, M D Touzé
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacinH B Drugeon, M E Juvin, A Bryskier
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complexP Bemer-Melchior, A Bryskier, H B Drugeon
Pathologie-Biologie|January 1, 1999
Diagnosis of extrapulmonary tuberculosis by a commercial polymerase chain reaction kitP Bemer-Melchior, P Germaud, H B Drugeon
Presse Medicale (Paris, France : 1983)|March 29, 1984
[Pharmacokinetics of azlocillin in the burn patient]H B Drugeon, M Pannier, A L Courtieu
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Chemotherapy|January 1, 1982
The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutantsH B Drugeon, A L Courtieu
Pathologie-Biologie|June 1, 1987
[Susceptibility of Campylobacter pyloridis to antibiotics]C Freland, B Massoubre, H B Drugeon
Fundamental & Clinical Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetilR Garraffo, H B Drugeon, D Chiche
Lancet (London, England)|March 10, 1990
Non-tuberculous mycobacterial tenosynovitisF Raffi, D Moinard, H B Drugeon
Pathologie-Biologie|May 1, 1987
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination]H B Drugeon, P Dellamonica, J Caillon
La Revue Du Praticien|April 11, 1987
[The Staphylococcus in 1987]D Baron, H B Drugeon, M D Touzé
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacinH B Drugeon, M E Juvin, A Bryskier
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complexP Bemer-Melchior, A Bryskier, H B Drugeon
Pathologie-Biologie|January 1, 1999
Diagnosis of extrapulmonary tuberculosis by a commercial polymerase chain reaction kitP Bemer-Melchior, P Germaud, H B Drugeon
Presse Medicale (Paris, France : 1983)|March 29, 1984
[Pharmacokinetics of azlocillin in the burn patient]H B Drugeon, M Pannier, A L Courtieu
Pageof 7